Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Samuel

Showing results (441-450 of 451) with videos related to

Pageof 46
Sort By:
Lancet (London, England)|February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyFabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
The Lancet. Oncology|November 7, 2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialValérie Vilgrain, Helena Pereira, Eric Assenat, et al.
Journal of Hepatology|March 8, 2020
Portopulmonary hypertension in the current era of pulmonary hypertension managementLaurent Savale, Manuel Guimas, Nathan Ebstein, et al.
Journal of Hepatology|September 10, 2020
Corrigendum to: "Portopulmonary hypertension in the current era of pulmonary hypertension management" [J Hepatol (2020);73:130-139]Laurent Savale, Manuel Guimas, Nathan Ebstein, et al.
Journal of Hepatology|May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.
Gastroenterology|April 8, 2014
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosisChristophe Hézode, Helene Fontaine, Celine Dorival, et al.
Hepatology International|July 24, 2015
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014Shiv Kumar Sarin, Chandan Kumar Kedarisetty, Zaigham Abbas, et al.
Hepatology International|July 31, 2025
Correction: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014Shiv Kumar Sarin, Chandan Kumar Kedarisetty, Zaigham Abbas, et al.
Transplantation|July 26, 2019
Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension StudyRené Adam, Vincent Karam, Valérie Cailliez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 11, 2022
Location and allocation: Inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in EuropeThierry Artzner, William Bernal, Luca S Belli, et al.
Pageof 46

Showing results (441-450 of 451) with videos related to

Sort By:
Pageof 46
Lancet (London, England)|February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyFabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
The Lancet. Oncology|November 7, 2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialValérie Vilgrain, Helena Pereira, Eric Assenat, et al.
Journal of Hepatology|March 8, 2020
Portopulmonary hypertension in the current era of pulmonary hypertension managementLaurent Savale, Manuel Guimas, Nathan Ebstein, et al.
Journal of Hepatology|September 10, 2020
Corrigendum to: "Portopulmonary hypertension in the current era of pulmonary hypertension management" [J Hepatol (2020);73:130-139]Laurent Savale, Manuel Guimas, Nathan Ebstein, et al.
Journal of Hepatology|May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.
Gastroenterology|April 8, 2014
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosisChristophe Hézode, Helene Fontaine, Celine Dorival, et al.
Hepatology International|July 24, 2015
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014Shiv Kumar Sarin, Chandan Kumar Kedarisetty, Zaigham Abbas, et al.
Hepatology International|July 31, 2025
Correction: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014Shiv Kumar Sarin, Chandan Kumar Kedarisetty, Zaigham Abbas, et al.
Transplantation|July 26, 2019
Improved Survival in Liver Transplant Patients Receiving Prolonged-release Tacrolimus-based Immunosuppression in the European Liver Transplant Registry (ELTR): An Extension StudyRené Adam, Vincent Karam, Valérie Cailliez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 11, 2022
Location and allocation: Inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in EuropeThierry Artzner, William Bernal, Luca S Belli, et al.
Pageof 46